The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Physical activity and molecular residual disease (MRD) in stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702.
 
George Zhang
No Relationships to Disclose
 
Chao Ma
No Relationships to Disclose
 
Qian Shi
Consulting or Advisory Role - Abbvie; Agenus; BeOne Medicines; BMS; Exelixis; Genmab US, Inc; Hoosier Cancer Research Network; HopeAI, Inc; Mirati Therapeutics; Regeneron
Research Funding - BMS (Inst); Janssen (Inst); MPAACT (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst)
 
Jonathan Nowak
Consulting or Advisory Role - Leica B
Research Funding - Natera
 
Levi Pederson
No Relationships to Disclose
 
Tyler Twombly
No Relationships to Disclose
 
Juha Väyrynen
No Relationships to Disclose
 
Melissa Zhao
No Relationships to Disclose
 
Yasutoshi Takashima
No Relationships to Disclose
 
Ardaman Shergill
Honoraria - Biyantara Foundation; Cholangiocarcinoma Foundation; Colon Cancer Alliance; Colon Cancer alliance; Great Debates in GI cancers
Consulting or Advisory Role - Guardant Health; Ipsen; Iterion Therapeutics; Merus; Pfizer; Pfizer; Revolution Medicines; Takeda
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BMS (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Gossamer Bio (Inst); Gritstone Bio (Inst); Hutchison MediPharma (Inst); Macrogenics (Inst); Merck (Inst); Oncologie (Inst); Pfizer (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst); Seattle Genetics/Astellas (Inst); Takeda (Inst); TP Therapeutics (Inst); verastem (Inst)
Travel, Accommodations, Expenses - colon cancer alliance; Ipsen; Merus; Revolution Medicines; Takeda
 
Pankaj Kumar
No Relationships to Disclose
 
Felix Couture
No Relationships to Disclose
 
J. Kuebler
Consulting or Advisory Role - Advarra
 
Smitha Krishnamurthi
Consulting or Advisory Role - Agenus; Bristol-Myers Squibb; Takeda
Research Funding - Agenus (Inst); Aravive (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties for two chapters I have written in UptoDate
 
Benjamin Tan
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck Serono (Inst); Tvardi Therapeutics (Inst); TYME (Inst)
 
Shuji Ogino
Consulting or Advisory Role - Sanofi Pasteur
 
Justin Brown
Honoraria - Novo Nordisk
 
Adham Jurdi
Employment - Natera
Stock and Other Ownership Interests - Agenus; Iovance Biotherapeutics; natera; Verastem
 
Anthony Shields
Consulting or Advisory Role - Caris Life Sciences; Cogent Biosciences; ImaginAb; Legend Biotech
Speakers' Bureau - Caris Life Sciences
Research Funding - Abbisko Therapeutics (Inst); Alkermes; Amal Therapeutics (Inst); Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Biomedical; Caris Life Sciences; Daiichi Sankyo; Eisai; Esperas Pharma; Esperas Pharma; Exelixis; Five Prime Therapeutics; Gritstone Bio (Inst); H3 Biomedicine; Halozyme; Hutchison China Meditech; IconOVir Bio (Inst); ImaginAb; Incyte; Inovio Pharmaceuticals; Jiangsu Alphamab Biopharmaceuticals; Lexicon; LSK BioPharma; MSK Pharma; Nouscom; Nuvation Bio (Inst); Plexxikon; Repertoire Immune Medicines; Seagen; Shanghai HaiHe Pharmaceutical; Sorrento Therapeutics (Inst); SQZ Biotechnology (Inst); Taiho Pharmaceutical; Telix Pharmaceuticals; TheraBionic (Inst); TopAlliance BioSciences Inc (Inst); Torque (Inst); Xencor
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget
 
Jeffrey Meyerhardt
Employment - Dana-Farber Cancer Institute; Newton Wellesley Hospital (I)
Speakers' Bureau - Research to Practice